Bioter S.A. (AT:BIOT) — Market Cap & Net Worth
Market Cap & Net Worth: Bioter S.A. (BIOT)
Bioter S.A. (AT:BIOT) has a market capitalization of $3.45 Million (€2.95 Million) as of October 3, 2026. Listed on the AT stock exchange, this Greece-based company holds position #29309 globally and #111 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Bioter S.A.'s stock price €0.21 by its total outstanding shares 16734800 (16.73 Million).
Bioter S.A. Market Cap History: 2015 to 2025
Bioter S.A.'s market capitalization history from 2015 to 2025. Data shows growth from $2.92 Million to $4.03 Million (6.45% CAGR). Check today's stock price for Bioter S.A. for real-time trading data and today's change.
Bioter S.A. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Bioter S.A.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Also see BIOT cash generation efficiency for how efficiently the company converts equity into cash flow.
Latest Price to Sales (P/S) Ratio
22.98x
Bioter S.A.'s market cap is 22.98 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $2.92 Million | $1.23 Million | -$10.17 Million | 2.38x | N/A |
| 2016 | $2.15 Million | $551.00K | -$18.32 Million | 3.91x | N/A |
| 2017 | $1.80 Million | $180.00K | -$17.52 Million | 10.00x | N/A |
| 2018 | $1.55 Million | $177.00K | -$12.80 Million | 8.73x | N/A |
| 2019 | $1.06 Million | $250.00K | -$8.89 Million | 4.23x | N/A |
| 2020 | $6.14 Million | $228.00K | $6.06 Million | 26.94x | 1.01x |
| 2021 | $7.16 Million | $246.00K | -$8.81 Million | 29.11x | N/A |
| 2022 | $5.79 Million | $252.00K | -$9.68 Million | 22.98x | N/A |
Competitor Companies of BIOT by Market Capitalization
Companies near Bioter S.A. in the global market cap rankings as of October 3, 2026. See BIOT equity to assets ratio to understand what proportion of total assets are financed by equity.
Key companies related to Bioter S.A. by market ranking:
- Quanta Services Inc (NYSE:PWR): Ranked #260 globally with a market cap of $99.62 Billion USD.
- Vinci S.A. (PA:DG): Ranked #412 globally with a market cap of $68.13 Billion USD ( €58.27 Billion EUR).
- Comfort Systems USA Inc (NYSE:FIX): Ranked #462 globally with a market cap of $59.31 Billion USD.
- Larsen & Toubro Limited (NSE:LT): Ranked #495 globally with a market cap of $54.95 Billion USD ( Rs5.08 Trillion INR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #260 | Quanta Services Inc | NYSE:PWR | $99.62 Billion | $662.60 |
| #412 | Vinci S.A. | PA:DG | $68.13 Billion | €105.60 |
| #462 | Comfort Systems USA Inc | NYSE:FIX | $59.31 Billion | $1685.29 |
| #495 | Larsen & Toubro Limited | NSE:LT | $54.95 Billion | Rs3693.40 |
Bioter S.A. Historical Marketcap From 2015 to 2025
Between 2015 and today, Bioter S.A.'s market cap moved from $2.92 Million to $ 4.03 Million, with a yearly change of 6.45%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | €4.03 Million | -17.60% |
| 2024 | €4.89 Million | +4.17% |
| 2023 | €4.70 Million | -18.92% |
| 2022 | €5.79 Million | -19.13% |
| 2021 | €7.16 Million | +16.56% |
| 2020 | €6.14 Million | +481.48% |
| 2019 | €1.06 Million | -31.65% |
| 2018 | €1.55 Million | -14.13% |
| 2017 | €1.80 Million | -16.36% |
| 2016 | €2.15 Million | -26.17% |
| 2015 | €2.92 Million | -- |
End of Day Market Cap According to Different Sources
On May 29th, 2026 the market cap of Bioter S.A. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $3.45 Million USD |
| MoneyControl | $3.45 Million USD |
| MarketWatch | $3.45 Million USD |
| marketcap.company | $3.45 Million USD |
| Reuters | $3.45 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Bioter S.A.
Bioter S.A. operates as a technical construction company in Greece and internationally. The company is involved in the execution of various projects, such as roads, ports, industrial-energy, electromechanical-communications, airports, war industries factories, etc., as well as private projects, such as offices, banks, bus stations, etc. The company was founded in 1961 and is based in Athens, Gree… Read more